An actively managed exchange-traded fund focused on companies developing genomic technologies, including gene editing, molecular diagnostics, agricultural biology, and bioinformatics. The portfolio primarily holds biotechnology and life sciences firms that ARK Invest believes could benefit from adva...
This page tracks all publicly disclosed congressional trades in ARK Genomic Revolution ETF (ARKG), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 3 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-03-25 | Dwight Evans | sell | $1K – $15K |
| 2022-03-25 | Dwight Evans | sell | $1K – $15K |
| 2021-11-02 | Dwight Evans | sell | $1K – $15K |
| 2020-10-29 | Dwight Evans | buy | $1K – $15K |